About
Hebbian Bio applies AI-driven drug target discovery using human patient biology models to develop novel treatments and biomarkers for central nervous system disorders, focusing initially on syndromic forms of autism.
Explore Hebbian Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.